Skip to main content

Table 3 Serum apoA-I levels in male and female NMO, ATM patients and healthy controls

From: Distinct serum apolipoprotein A-I levels in neuromyelitis optica and acute transverse myelitis

  Female ApoA-I (g/L) Male ApoA-I(g/L) p1 p2 p3
Age Age
NMO 38.1 ± 13.2 1.21 ± 0.23 38.5 ± 17.3 1.17 ± 0.17 0.001*a 0.002*a 0.471
ATM 39.8 ± 16.1 1.43 ± 0.22 38.6 ± 16.4 1.34 ± 0.19 0.001*b <0.001**b 0.056
HC 39.3 ± 18.7 1.67 ± 0.21 42.5 ± 16.8 1.52 ± 0.16 <0.001**c <0.001**c <0.001**
  1. Data are means ± SD. p1, Compared serum apoA-I levels among three female groups; p2, Compared serum apoA-I levels among three male groups; aNMO versus ATM; bATM versus HC; cNMO versus HC; p3, Compared serum apoA-I levels between female and male NMO patients, and female and male patients in other two groups.
  2. *Difference is significant below the 0.01 level.
  3. **Difference is significant below the 0.001 level.